Evolv Technologies Holdings, Inc.

NasdaqCM:EVLV Voorraadrapport

Marktkapitalisatie: US$893.0m

Evolv Technologies Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Evolv Technologies Holdings heeft een totaal eigen vermogen van $118.9M en een totale schuld van $28.7M, wat de schuld-eigenvermogensverhouding op 24.2% brengt. De totale activa en totale passiva bedragen respectievelijk $302.0M en $183.2M.

Belangrijke informatie

24.18%

Verhouding schuld/eigen vermogen

US$28.74m

Schuld

Rente dekkingsration/a
ContantUS$62.63m
AandelenUS$118.86m
Totaal verplichtingenUS$183.17m
Totaal activaUS$302.02m

Recente financiële gezondheidsupdates

Recent updates

Narratiefupdate • Sep 08

EVLV: 2026 Manufacturing Ramp And New Contracts Will Drive Upside

Analysts have trimmed their fair value estimate for Evolv Technologies Holdings from $10.00 to $8.00. This aligns it with a new $8.00 price target that reflects updated assumptions for revenue growth, profit margins and future P/E expectations following recent research coverage.
Analyse-artikel • Jun 21

Evolv Technologies Holdings (EVLV) Stock Could Be 43.5% Undervalued After DHS SAFETY Act Designation

Evolv Technologies Holdings (EVLV) is back in focus after the US Department of Homeland Security granted SAFETY Act Designation to its Evolv eXpedite bag screening system, placing both core products on the Qualified Anti-Terrorism Technologies list. See our latest analysis for Evolv Technologies Holdings. Even with the SAFETY Act news drawing fresh attention, Evolv Technologies Holdings’ share price has been under pressure in 2026, with the year to date share price return down 15.67% and the...
Narratiefupdate • Jun 16

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Analysts have maintained their consolidated price target for Evolv Technologies Holdings at $10.50, citing recent Q1 results, clarification of misreported data, and commentary on revenue trends, margins, and longer term manufacturing benefits as key supports for this level. Analyst Commentary on Evolv Technologies Holdings Recent research coverage on Evolv Technologies Holdings centers on the Q1 report, the clarification of misreported information via an 8-K filing, and updated views on revenue growth, margins, and longer term manufacturing plans.
Narratiefupdate • Jun 02

EVLV: 2026 Contract Manufacturing Ramp Will Drive Long Term Upside

Analysts have nudged their average price target on Evolv Technologies Holdings higher from $9.50 to $10.00, pointing to what they see as strong Q1 execution, improved RPO growth, and the potential for 2026 to mark a positive inflection in growth and profitability, despite recent share price dislocation linked to reporting confusion. Analyst Commentary Recent research highlights a generally constructive stance on Evolv Technologies Holdings after Q1, with several firms pointing to what they see as strong execution, raised guidance, and improving contract metrics such as remaining performance obligations.
Narratiefupdate • May 02

EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside

Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
Narratiefupdate • Apr 18

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
Narratiefupdate • Apr 03

EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside

Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.
Narratiefupdate • Mar 20

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
Narratiefupdate • Mar 06

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).
Narratiefupdate • Feb 20

EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026

Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.
Narratiefupdate • Feb 05

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.
Narratiefupdate • Jan 22

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.
Narratiefupdate • Jan 08

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.
Narratiefupdate • Dec 14

EVLV: ARR Momentum Will Drive A Breakout Year In 2026

Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.
Narratiefupdate • Aug 16

Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.
User avatar
Nieuw narratief • Jun 01

AI Screening Will Expand Public Safety Applications

Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.
Analyse-artikel • May 21

The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%

Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $149.4M ) EVLV } overtreffen de korte termijn passiva ( $126.8M ).

Langlopende schulden: De kortetermijnactiva EVLV ( $149.4M ) overtreffen de langetermijnschulden ( $56.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: EVLV heeft meer geld in kas dan de totale schuld.

Schuld verminderen: EVLV had 5 jaar geleden een negatief eigen vermogen, maar is nu positief en is dus verbeterd.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: EVLV heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of EVLV voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/10 10:24
Aandelenkoers aan het einde van de dag2026/09/10 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Evolv Technologies Holdings, Inc. wordt gevolgd door 5 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jeremy HamblinCraig-Hallum Capital Group LLC
Eric MartinuzziLake Street Capital Markets, LLC
Michael LatimoreNorthland Capital Markets